Page last updated: 2024-10-29

ketoconazole and Experimental Neoplasms

ketoconazole has been researched along with Experimental Neoplasms in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajendran, P1
Jaggi, M1
Singh, MK1
Mukherjee, R1
Burman, AC1
Braunschweiger, PG1
Kumar, N1
Constantinidis, I1
Wehrle, JP1
Glickson, JD1
Johnson, CS1
Furmanski, P1

Other Studies

2 other studies available for ketoconazole and Experimental Neoplasms

ArticleYear
Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
    Investigational new drugs, 2008, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Betulinic Acid; Blood Proteins; Cell Line, Tumor;

2008
Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole.
    Cancer research, 1990, Aug-01, Volume: 50, Issue:15

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Corticosterone; E

1990